(Q68377555)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2126987%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

title

Combination treatment using thymosin alpha 1 and interferon after cyclophosphamide is able to cure Lewis lung carcinoma in mice (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2126987%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2126987%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

author name string

E Garaci

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2126987%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

A Mastino

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2126987%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

C Favalli

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2126987%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

publication date

1 January 1990

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2126987%20AND%20SRC:MED&resulttype=core&format=json

Cancer Immunology, Immunotherapy

23 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2126987%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

volume

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2126987%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2126987%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

page(s)

154-160

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2126987%20AND%20SRC:MED&resulttype=core&format=json

Effect of low-dose cyclophosphamide therapy on specific and nonspecific T cell-dependent immune responses of spleen cells from mice bearing large MOPC-315 plasmacytomas

23 September 2019

cites work

1 reference

12 December 2020

Human natural killer cells: biologic and pathologic aspects

1 reference

12 December 2020

Thymosin increases production of T-cell growth factor by normal human peripheral blood lymphocytes

1 reference

12 December 2020

Characterization of T-lymphocyte subpopulations infiltrating primary breast cancer

1 reference

12 December 2020

Modulation of interleukin 2 receptor expression on normal human lymphocytes by thymic hormones

1 reference

12 December 2020

Thymosin alpha1: isolation and sequence analysis of an immunologically active thymic polypeptide

1 reference

12 December 2020

Changes in the host natural killer cell population in mice during tumor development. 1. Kinetics and in vivo significance.

1 reference

12 December 2020

Reconstitution of T cell functions in aging mice by thymosin alpha 1

1 reference

12 December 2020

Tumour inhibition by interleukin-2 at the tumour/host interface

1 reference

12 December 2020

Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells

1 reference

12 December 2020

In vitro migration of rat large granular lymphocytes

1 reference

12 December 2020

In vivo distribution of adoptively transferred indium-111-labeled tumor infiltrating lymphocytes and peripheral blood lymphocytes in patients with metastatic melanoma

1 reference

12 December 2020

The cytolytic and regulatory role of natural killer cells in human neoplasia

1 reference

12 December 2020

Thymosin fraction V and intensive combination chemotherapy. Prolonging the survival of patients with small-cell lung cancer

1 reference

12 December 2020

Improved therapeutic effects of interleukin 2 after the accumulation of lymphokine-activated killer cells in tumor tissue of mice previously treated with cyclophosphamide

1 reference

12 December 2020

Combined effects of chemotherapy and interleukin 2 in the therapy of mice with advanced pulmonary tumors

1 reference

12 December 2020

Enhanced immune response and antitumor immunity with combinations of biological response modifiers

1 reference

12 December 2020

Synergistic effect of thymosin alpha 1 and alpha beta-interferon on NK activity in tumor-bearing mice

1 reference

12 December 2020

Modulation of human natural killer cell cytotoxic activity, lymphokine production, and interleukin 2 receptor expression by thymic hormones

1 reference

12 December 2020

Correlation between in vivo and in vitro studies of modulation of resistance to experimental Candida albicans infection by cyclophosphamide in mice

1 reference

12 December 2020

Modulation of natural killer activity by thymosin alpha 1 and interferon

1 reference

12 December 2020

Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic acid allogeneic tumors. I. Distribution of reactivity and specificity

1 reference

12 December 2020

Modulation of immune response and tumor development in tumor-bearing mice treated by the thymic factor thymostimulin

1 reference

12 December 2020

Thymosin alpha 1 restores NK-cell activity and prevents tumor progression in mice immunosuppressed by cytostatics or X-rays

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01771450

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2126987%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

1 reference